143 related articles for article (PubMed ID: 2014254)
1. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees.
Gibbs CJ; Peters R; Gravell M; Johnson BK; Jensen FC; Carlo DJ; Salk J
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3348-52. PubMed ID: 2014254
[TBL] [Abstract][Full Text] [Related]
2. Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus.
Girard M; van der Ryst E; Barré-Sinoussi F; Nara P; Tartaglia J; Paoletti E; Blondeau C; Jennings M; Verrier F; Meignier B; Fultz PN
Virology; 1997 May; 232(1):98-104. PubMed ID: 9185593
[TBL] [Abstract][Full Text] [Related]
3. Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge.
Niedrig M; Gregersen JP; Fultz PN; Bröker M; Mehdi S; Hilfenhaus J
Vaccine; 1993; 11(1):67-74. PubMed ID: 8427039
[TBL] [Abstract][Full Text] [Related]
4. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.
Arthur LO; Bess JW; Waters DJ; Pyle SW; Kelliher JC; Nara PL; Krohn K; Robey WG; Langlois AJ; Gallo RC
J Virol; 1989 Dec; 63(12):5046-53. PubMed ID: 2555541
[TBL] [Abstract][Full Text] [Related]
5. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Girard M; Kieny MP; Pinter A; Barre-Sinoussi F; Nara P; Kolbe H; Kusumi K; Chaput A; Reinhart T; Muchmore E
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):542-6. PubMed ID: 1988952
[TBL] [Abstract][Full Text] [Related]
6. Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.
Berman PW; Murthy KK; Wrin T; Vennari JC; Cobb EK; Eastman DJ; Champe M; Nakamura GR; Davison D; Powell MF; Bussiere J; Francis DP; Matthews T; Gregory TJ; Obijeski JF
J Infect Dis; 1996 Jan; 173(1):52-9. PubMed ID: 8537682
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.
Girard M; Meignier B; Barré-Sinoussi F; Kieny MP; Matthews T; Muchmore E; Nara PL; Wei Q; Rimsky L; Weinhold K
J Virol; 1995 Oct; 69(10):6239-48. PubMed ID: 7666524
[TBL] [Abstract][Full Text] [Related]
8. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.
Shibata R; Siemon C; Cho MW; Arthur LO; Nigida SM; Matthews T; Sawyer LA; Schultz A; Murthy KK; Israel Z; Javadian A; Frost P; Kennedy RC; Lane HC; Martin MA
J Virol; 1996 Jul; 70(7):4361-9. PubMed ID: 8676459
[TBL] [Abstract][Full Text] [Related]
9. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.
Fultz PN; Nara P; Barre-Sinoussi F; Chaput A; Greenberg ML; Muchmore E; Kieny MP; Girard M
Science; 1992 Jun; 256(5064):1687-90. PubMed ID: 1609280
[TBL] [Abstract][Full Text] [Related]
10. Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.
Zolla-Pazner S; Lubeck M; Xu S; Burda S; Natuk RJ; Sinangil F; Steimer K; Gallo RC; Eichberg JW; Matthews T; Robert-Guroff M
J Virol; 1998 Feb; 72(2):1052-9. PubMed ID: 9444999
[TBL] [Abstract][Full Text] [Related]
11. Immunization of chimpanzees with recombinant gp160, but not infection with human immunodeficiency virus type 1, induces envelope-specific Th1 memory cells.
Mannhalter JW; Fischer MB; Wolf HM; Küpcü Z; Barrett N; Dorner F; Eder G; Eibl MM
J Infect Dis; 1995 Feb; 171(2):437-40. PubMed ID: 7844384
[TBL] [Abstract][Full Text] [Related]
12. Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.
el-Amad Z; Murthy KK; Higgins K; Cobb EK; Haigwood NL; Levy JA; Steimer KS
AIDS; 1995 Dec; 9(12):1313-22. PubMed ID: 8605050
[TBL] [Abstract][Full Text] [Related]
13. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.
Conley AJ; Kessler JA; Boots LJ; McKenna PM; Schleif WA; Emini EA; Mark GE; Katinger H; Cobb EK; Lunceford SM; Rouse SR; Murthy KK
J Virol; 1996 Oct; 70(10):6751-8. PubMed ID: 8794312
[TBL] [Abstract][Full Text] [Related]
14. Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.
Arthur LO; Pyle SW; Nara PL; Bess JW; Gonda MA; Kelliher JC; Gilden RV; Robey WG; Bolognesi DP; Gallo RC
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8583-7. PubMed ID: 3479807
[TBL] [Abstract][Full Text] [Related]
15. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
16. Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model.
Moss RB; Savary JR; Diveley JP; Jensen F; Carlo DJ
Immunology; 2002 Aug; 106(4):549-53. PubMed ID: 12153518
[TBL] [Abstract][Full Text] [Related]
17. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.
Prince AM; Horowitz B; Baker L; Shulman RW; Ralph H; Valinsky J; Cundell A; Brotman B; Boehle W; Rey F
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6944-8. PubMed ID: 3413127
[TBL] [Abstract][Full Text] [Related]
18. Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjects.
Moss RB; Giermakowska W; Lanza P; Turner JL; Wallace MR; Jensen FC; Theofan G; Richieri SP; Carlo DJ
Viral Immunol; 1997; 10(4):221-8. PubMed ID: 9473153
[TBL] [Abstract][Full Text] [Related]
19. Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.
Pincus SH; Messer KG; Hu SL
J Clin Invest; 1994 Jan; 93(1):140-6. PubMed ID: 8282780
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees.
Belo M; Yagello M; Girard M; Greenlee R; Deslandres A; Barré-Sinoussi F; Gluckman JC
AIDS; 1991 Feb; 5(2):169-76. PubMed ID: 2031689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
